论文部分内容阅读
我院自1989年11月以来采用经皮肝动脉灌注化疗药物(TAI)及栓塞剂(TAE)治疗不能手术切除的原发性肝癌17例,获一定疗效。资料与方法本组男15例,女2例,年龄31～63岁,平均51.4岁。肿瘤直径2.5～24.0cm,平均11.5cm,AFP<25ng/ml 2例,25～400ng/ml 3例,401～1000ng/ml 8例,>1000ng/ml 4例。位于右叶13例,左右叶4例,符合巨块型14例,弥漫型1例,结节型2例;Ⅰ期2例,Ⅱ期10例,Ⅲ期5例。均采
In our hospital since November 1989, percutaneous transhepatic arterial infusion chemotherapy (TAI) and embolic agent (TAE) have been used to treat 17 cases of primary hepatocellular carcinoma that cannot be surgically treated, and have obtained certain effects. Data and Methods The group of 15 males and 2 females, aged 31 to 63 years, mean 51.4 years old. Tumor diameter was 2.5 to 24.0 cm, average 11.5 cm, AFP <25 ng/ml in 2 cases, 25 to 400 ng/ml in 3 cases, 401 to 1000 ng/ml in 8 cases, and >1000 ng/ml in 4 cases. In the right lobe in 13 cases, left and right lobes in 4 cases, in line with the massive type in 14 cases, diffuse in 1 case, nodular in 2 cases; I in 2 cases, II in 10 cases, III in 5 cases. All mining